Overview
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 2 days early.
- 202514/07/2026
- 202413/07/2025
- 202314/07/2024
- 202213/07/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, a member of the management board is authorised to represent the company independently, whereas in the case of a multi-member management board, two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy are authorised to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marek Roszkiewiczage 37 | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-11-01.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| BiotonS.A. | $72,911,351.08 | bioton.com | ||
| Celon PharmaS.A. | $52,550,739.16 | celonpharma.com | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| VipharmS.A. | $30,660,173.61 | vipharm.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
FAQ
Last updated: 2026-10-07